A study of 2155 men with prostate cancer found that active surveillance is a suitable alternative to immediate surgery or radiation for those with low risk of metastasis. The Canary Prostate Active Surveillance (Pass) study showed that after 10 years, nearly half of the men had no disease progression, with very low rates of metastatic disease and death from prostate cancer. The study suggests that monitoring men with low-risk prostate cancer may be a viable option, with favorable outcomes in terms of disease progression and overall survival. These findings were reported in JAMA.
Source link